{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:44:42Z","timestamp":1787013882201,"version":"build-2736575974"},"reference-count":37,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T00:00:00Z","timestamp":1349222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The pathophysiological mechanisms which contribute to an increased risk of community\u2010acquired pneumonia (\n                      <jats:styled-content style=\"fixed-case\">CAP<\/jats:styled-content>\n                      ) in patients using proton pump inhibitors are not well established.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>\n                      To examine differences in microbial etiology in patients with\n                      <jats:styled-content style=\"fixed-case\">CAP<\/jats:styled-content>\n                      between patients with and without proton pump inhibitor (\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      ) therapy and its possible impact on disease severity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      All individuals consulting the emergency care unit were prospectively registered and underwent chest radiography. Sputum, urine, nose\u2010throat swabs and blood samples were obtained for microbial evaluation. We evaluated the association between use of proton pump inhibitors, etiology of\n                      <jats:styled-content style=\"fixed-case\">CAP<\/jats:styled-content>\n                      and severity of illness with multivariate regression analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The final cohort comprised 463 patients, 29% using proton pump inhibitors (\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      s). Pathogens regarded as oropharyngeal flora were more common in\n                      <jats:styled-content style=\"fixed-case\">CAP<\/jats:styled-content>\n                      patients using\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      therapy compared to those who did not (adjusted\n                      <jats:styled-content style=\"fixed-case\">OR<\/jats:styled-content>\n                      : 2.0; 95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 1.22\u20133.72). Patients using proton pump inhibitors more frequently had an infection with\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                        treptococcus pneumoniae\n                      <\/jats:italic>\n                      (28% vs. 14%) and less frequently with\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">C<\/jats:styled-content>\n                        oxiella burnetii\n                      <\/jats:italic>\n                      (8% vs. 19%) compared to nonuser of\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      . Adjusted for baseline differences, the risk of\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      users being infected with\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                        . pneumonia\n                      <\/jats:italic>\n                      was 2.23 times (95%\n                      <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content>\n                      : 1.28\u20133.75) higher compared to patients without\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      's. No risk between\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      use and any other microbial pathogen was found. There was no difference in severity of\n                      <jats:styled-content style=\"fixed-case\">CAP<\/jats:styled-content>\n                      between patients with and without using\n                      <jats:styled-content style=\"fixed-case\">PPI<\/jats:styled-content>\n                      therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Proton pump inhibitor therapy was associated with an approximately 2\u2010fold increased risk to develop community\u2010acquired pneumonia possibly as a result of\n                      <jats:italic>\n                        <jats:styled-content style=\"fixed-case\">S<\/jats:styled-content>\n                        . pneumoniae\n                      <\/jats:italic>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/apt.12069","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T21:27:12Z","timestamp":1349299632000},"page":"941-949","source":"Crossref","is-referenced-by-count":66,"title":["Proton pump inhibitor therapy predisposes to community\u2010acquired\n                    <i>\n                      <scp>S<\/scp>\n                      treptococcus pneumoniae\n                    <\/i>\n                    pneumonia"],"prefix":"10.1111","volume":"36","author":[{"given":"C. P. C.","family":"de Jager","sequence":"first","affiliation":[{"name":"Departments of Intensive Care and Emergency Medicine \u2018s\u2010Hertogenbosch The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C.","family":"Wever","sequence":"additional","affiliation":[{"name":"Medical Microbiology and Infection Control Jeroen Bosch Hospital \u2018s\u2010Hertogenbosch The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. F. A.","family":"Gemen","sequence":"additional","affiliation":[{"name":"Clinical Chemistry \u2018s\u2010Hertogenbosch The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G. H.","family":"van Oijen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"van Gageldonk\u2010Lafeber","sequence":"additional","affiliation":[{"name":"National Institute for Public Health and the Environment (RIVM) Centre for Infectious Disease Control Bilthoven The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. D.","family":"Siersema","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. C. M.","family":"Kusters","sequence":"additional","affiliation":[{"name":"Clinical Chemistry \u2018s\u2010Hertogenbosch The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J. F.","family":"Laheij","sequence":"additional","affiliation":[{"name":"Departments of Intensive Care and Emergency Medicine \u2018s\u2010Hertogenbosch The Netherlands"},{"name":"Department of Gastroenterology and Hepatology University Medical Center Utrecht Utrecht The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,3]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1086\/511159"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e31824b228f"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.16.1955"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04284.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831070-00008"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.2.179"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04874.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.46"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e32833ea9d9"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.39.1.54"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02707.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2001.0191"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200703-456SO"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91208-4"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7269.1103"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-8-199404150-00005"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00020811"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00888.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.5.377"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01744.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.722"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026604203237"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.014s1074.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200205000-00026"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.3109\/08923970009016425"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03900.x"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02982.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3003.2000.15d21.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.2.109"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.2.9808045"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.13.1729"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02918.x"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04890.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302371"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.032912"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90173-9"},{"key":"e_1_2_6_38_1","first-page":"382","article-title":"Q fever in the Netherlands from 2007 to 2010","volume":"68","author":"Delsing CE","year":"2010","journal-title":"Neth J Med"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.12069","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.12069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T15:52:15Z","timestamp":1695484335000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.12069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,3]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1111\/apt.12069"],"URL":"https:\/\/doi.org\/10.1111\/apt.12069","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,3]]}}}